Type 2 Diabetes Mellitus in Children and Youth: A New Epidemic
- 1 January 2002
- journal article
- review article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 15 (Supplement) , 737-744
- https://doi.org/10.1515/jpem.2002.15.s2.737
Abstract
Type 2 diabetes mellitus (DM) has been described as a new epidemic affecting the American pediatric population. This is coincident with an overall 33% increase in DM prevalence documented during the last decade. In 1992, type 2 DM was a rare occurrence in most pediatric centers. By 1994, it represented up to 16% of new cases in urban areas, and by 1999, the incidence of new type 2 DM diagnoses ranged between 8% and 45%, depending on geographic location. These patients have been observed primarily in African American, Mexican American, Native American, and Asian American children and youth. As in the adult population, type 2 DM in children and youth occurs as a result of insulin resistance coupled with relative beta-cell failure. While there appears to be a host of potential genetic and environmental risk factors for these aberrations, perhaps the most significant risk factor is obesity. Other risk factors include a family history of type 2 DM, puberty, intrauterine exposure to DM, sedentary lifestyle, female gender, and certain ethnicities. To date, few studies have addressed the role of physical activity and nutrition counseling in improving glycemic outcome, the most effective ways to reduce cardiovascular risk, or the most effective treatment regimens for this population. Once type 2 DM is established, the persistence of obesity often interferes with the response to treatment and exacerbates the comorbidities of hypertension, dyslipidemia, atherosclerosis, and polycystic ovarian syndrome (PCOS). Since fewer than 10% of youth with type 2 DM can be treated with diet and exercise alone, pharmacological intervention is generally required to achieve normoglycemic targets. In most surveys, practitioners prescribe insulin or an oral agent, most often metformin. Specific treatment algorithms for pediatric patients with type 2 DM need to be rigorously investigated.Keywords
This publication has 14 references indexed in Scilit:
- Dihydrotestosterone Treatment in Adolescents with Delayed Puberty: Does it Explain Insulin Resistance of Puberty?Journal of Clinical Endocrinology & Metabolism, 2001
- A National Short-Term Follow-Up Study of Extremely Low Birth Weight Infants Born in Finland in 1996–1997Pediatrics, 2001
- Type 2 diabetes among North adolescents: An epidemiologic health perspectiveThe Journal of Pediatrics, 2000
- Correlations between the intrauterine metabolic environment and blood pressure in adolescent offspring of diabetic mothersThe Journal of Pediatrics, 2000
- Pubertal African-American Girls Expend Less Energy at Rest and During Physical Activity than Caucasian GirlsJournal of Clinical Endocrinology & Metabolism, 1999
- Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected WomenJournal of Clinical Endocrinology & Metabolism, 1999
- Non-Insulin Dependent Diabetes Mellitus in African-American Youths of ArkansasClinical Pediatrics, 1998
- Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of pubertyDiabetes, 1994
- GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetesDiabetes, 1994
- High prevalence of diabetes in young Pima Indians: evidence of phenotypic variation in a genetically isolated populationDiabetes, 1979